CFO
Sun Pharmaceutical Industries Limited
Equibles does not estimate personal net worth.
Jayshree Satgopan is recorded as CFO at Sun Pharmaceutical Industries Limited. Jayshree Satgopan has spoken on 4 earnings calls across 1 company, most recently for Sun Pharmaceutical Industries Limited on October 30, 2026. Sun Pharmaceutical Industries Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“After the announcement The financials are already with me. Let me take you through the key consolidated financials. During the second quarter of FY27, sales were at $161,000,000,00, registering a growth of 11.8% vis-à-vis Q2 FY26.”
“Welcome and thank you for joining us for the earnings call after the announcement of financial results for the first quarter of FY2027. The financials are already with you.”
“Registering a growth of 13.6% vis-à-vis Q4 FI25. Gross margin was at 80.8% for the quarter, higher than the same period last year, largely on account of better product mix.”
“Welcome and thank you for joining us for this earnings call after the announcement of financial results for the third quarter of FI 2026. Our Q3 financials are already with you.”
Sun Pharmaceutical Industries Limited
CFO
Transcript header (unverified)
Sun Pharmaceutical Industries Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call
Sun Pharmaceutical Industries Limited
Sun Pharma Q1 FY27 Earnings Call Transcript
Sun Pharmaceutical Industries Limited
Sun Pharma Q4 FY26 Earnings Call Transcript
Sun Pharmaceutical Industries Limited
Sun Pharma Q3 FY26 Earnings Call Transcript
Sun Pharmaceutical Industries Limited
